[Advances in the study of nucleoside antiviral drugs].
Liu
Kun
K
Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850, China.
Xie
Lan
L
D000225:Adenine / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D019380:Anti-HIV Agents / Q000737:chemistry / Q000494:pharmacology*; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology; D004148:Dioxolanes / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D015394:Molecular Structure; D009705:Nucleosides / Q000737:chemistry / Q000494:pharmacology*; D063065:Organophosphonates / Q000737:chemistry / Q000494:pharmacology; D011684:Purine Nucleosides / Q000737:chemistry / Q000494:pharmacology; D000068698:Tenofovir
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D004148:Dioxolanes; D009705:Nucleosides; D063065:Organophosphonates; D011684:Purine Nucleosides; D001086:Arabinofuranosyluracil; C098393:amdoxovir; D003596:Cytosine; D000068698:Tenofovir; C034935:clevudine; D000225:Adenine; D000077404:Cidofovir